Bicycle Therapeutics
Bicycle Therapeutics is a biopharmaceutical company developing precision-guided therapeutics based on its proprietary Bicycle® technology platform, primarily targeting solid tumor cancers.
No open positions right now. Check back soon!
Browse all jobsAbout the company
Bicycle Therapeutics is a biopharmaceutical company developing precision-guided therapeutics based on its proprietary Bicycle® technology platform, primarily targeting solid tumor cancers. The company also explores applications in other therapeutic areas including anti-infective, cardiovascular, ophthalmology, dementia, central nervous system, neuromuscular, and respiratory diseases. It operates with offices in Cambridge, United Kingdom and Lexington, Massachusetts, USA, and its leadership team includes a Chief Executive Officer, Chief Medical Officer, and Chief Scientific Officer.
Bicycle Therapeutics has no offices in Spain, and the current job openings are based in Cambridge, UK and Lexington, MA, USA. The company's mission is to make a life-changing impact on patients with cancer and other diseases, and it collaborates with pharma partners and academic thought leaders. For international professionals, the company offers roles in development, such as Senior Director, Statistical Programming and Senior Director, Biostatistics, but these positions are not located in Spain.
For International Professionals
- Bicycle Therapeutics has offices in Cambridge, UK and Lexington, MA, USA, but no offices in Spain.
- Current job openings are located in Cambridge, UK and Lexington, MA, USA, not in Spain.
- The company focuses on developing precision-guided therapeutics for solid tumors and other diseases.
- The company's mission is to make a life-changing impact on patients with cancer and other diseases.
- The company collaborates with pharma partners and academic thought leaders in various therapeutic areas.
Company History
Bicycle Therapeutics is a biopharmaceutical company developing a new class of precision-guided therapeutics based on its proprietary Bicycle® technology platform. The company focuses on creating targeted medicines for solid tumor cancers and exploring applications in other therapeutic areas such as anti-infective, cardiovascular, and central nervous system diseases. It operates with a leadership team and advisory boards, with offices in Cambridge, UK and Lexington, MA, USA.